196 related articles for article (PubMed ID: 31014937)
21. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.
Sørgjerd EP
Curr Diabetes Rev; 2019; 15(3):199-204. PubMed ID: 30058495
[TBL] [Abstract][Full Text] [Related]
22. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
[TBL] [Abstract][Full Text] [Related]
23. [Association of autoantibody and cytokines with latent autoimmune diabetes in adults].
He FP
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1323-5. PubMed ID: 14678903
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus].
Zhang L; Shi YL; Hong WX; Jia WD; Li LH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1034-6. PubMed ID: 16864107
[TBL] [Abstract][Full Text] [Related]
25. Combined measurement of diabetes mellitus immunological markers: an assessment of its benefits in adult-onset patients.
Valdez SN; Sica MP; Labovsky V; Iacono RF; Cardoso AL; Krochik AG; Mazza CS; Ermácora MR; Cédola N; Poskus E
Autoimmunity; 2001; 33(4):227-36. PubMed ID: 11683397
[TBL] [Abstract][Full Text] [Related]
26. Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.
Abdel-Latif M; Abdel-Moneim AA; El-Hefnawy MH; Khalil RG
Clin Exp Immunol; 2017 Oct; 190(1):110-121. PubMed ID: 28640379
[TBL] [Abstract][Full Text] [Related]
27. Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.
Ng WY; Thai AC; Lui KF; Yeo PP; Cheah JS
Diabetes Res Clin Pract; 1999 Feb; 43(2):127-35. PubMed ID: 10221665
[TBL] [Abstract][Full Text] [Related]
28. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
29. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
30. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
[TBL] [Abstract][Full Text] [Related]
31. Influence of age at diagnosis and duration of diabetes on the positivity of glutamic acid decarboxylase antibody in South-Brazilian type 1 diabetes mellitus.
Maraschin Jde F; Weinert LS; Murussi N; Witter V; Rodrigues Tda C; Rossato ER; Silveiro SP
Ann Clin Biochem; 2013 May; 50(Pt 3):262-6. PubMed ID: 23610212
[TBL] [Abstract][Full Text] [Related]
32. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
33. Early-pregnancy cytokines in mothers to children developing multiple, persistent islet autoantibodies, type 1 diabetes, or both before 7 years of age.
Lindehammer SR; Fex M; Maziarz M; Hanson I; Maršál K; Lernmark A;
Am J Reprod Immunol; 2011 Dec; 66(6):495-503. PubMed ID: 21819478
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
35. Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus.
Giustina A; Desenzani P; Perini P; Bazzigaluppi E; Bodini C; Bossoni S; Poiesi C; Wehrenberg WB; Bosi E
Metabolism; 1997 Apr; 46(4):382-7. PubMed ID: 9109840
[TBL] [Abstract][Full Text] [Related]
36. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics and classification of 2128 outpatients with diabetes].
Qi HY; Zhou ZG; Li X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):184-6. PubMed ID: 16145908
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients.
Chang YH; Shiau MY; Tsai ST; Lan MS
Biochem Biophys Res Commun; 2004 Jul; 320(3):802-9. PubMed ID: 15240119
[TBL] [Abstract][Full Text] [Related]
39. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
40. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
